Inc. (“Forward” or the “Company”), a clinical-stage biotechnology company developing oral small molecule therapies for inflammation-driven diseases, today announced positive Phase 1 clinical and ...

Vertical Aerospace adds advanced structural repair, engineering and fabricated part manufacturing capabilities and a ...

MAN Truck & Bus and Stadtwerke München, working with Münchner Verkehrsgesellschaft and the City of Munich’s Mobility ...

A closer look at what you can expect to spend on a one-way ticket and how to redeem miles for business class on the A350.

In the 8-week study, ATR-258 was well-tolerated and associated with an approximately 13% mean improvement in lower extremity muscle power in combination with a beneficial effect on body composition, ...

The financing will fully fund the advancement of AnaCardio's lead candidate, AC01, through Phase 2b clinical development in patients with chronic advanced heart failure with reduced ejection fraction ...

Inventory and liquidity were positioned as strategic assets supporting sales timing: Adnani said UEC ended the year “holding 1.26 million pounds of uranium in inventory worth about $109 million at ...

Menin acts as a molecular brake on pancreatic β- cell proliferation. With its menin inhibitor platform, Caspian is pursuing a potentially disease-modifying approach designed to increase functional β- ...

For students preparing for the CBSE Class 12 Mathematics Board Exam 2027, understanding the official marks distribution can ...

Caspian Therapeutics, Inc. and Kura Oncology, Inc. announced comprehensive preclinical data supporting KO-7246 as a potential best-in-class menin inhibitor for diabetes. KO-7246 regenerated functional ...